Cantitate/Preț
Produs

Statistical Methodology in the Pharmaceutical Sciences: Statistics: A Series of Textbooks and Monographs

Autor D. A. Berry
en Limba Engleză Hardback – 28 sep 1989
A state-of-the-art handbook of statistical analysis for use in the pharmaceutical industry. Areas covered in this reference/text include: bioavailability, repeated-measures designs, dose-response, population models, multicenter trials, handling dropouts, survival analysis, robust data analysis, cate
Citește tot Restrânge

Din seria Statistics: A Series of Textbooks and Monographs

Preț: 271969 lei

Preț vechi: 331669 lei
-18%

Puncte Express: 4080

Carte tipărită la comandă

Livrare economică 11-25 iulie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.

Specificații

ISBN-13: 9780824781170
ISBN-10: 0824781171
Pagini: 596
Dimensiuni: 152 x 229 x 37 mm
Greutate: 1.26 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Statistics: A Series of Textbooks and Monographs


Cuprins

Preface Contributors. 1. Basic Principles in Designing and Analyzing Clinical Studies. 2. Bioavailability: Designs and Analysis. 3. Analysis of Repeated-Measures Designs. 4. Dose-Response: Relating Doses and Plasma Levels to Efficacy and Adverse Experiences. 5. Population Models. 6. Linear and Nonlinear Regression. 7. Design and Analysis of Multicenter Trials. 8. Crossover Versus Parallel Designs. 9. Handling Dropouts and Related Issues. 10. Group Sequential Methods in Clinical Trials. 11. Survival Analysis. 12. Robust Data Analysis. 13. Categorical Data Analysis. 14. Causality Assessment for Adverse Drug Reactions. 15. Bayesian Metaanalysis. 16. Inferential Problems in Postmarketing Surveillance. Index

Descriere

A state-of-the-art handbook of statistical analysis for use in the pharmaceutical industry. Areas covered in this reference/text include: bioavailability, repeated-measures designs, dose-response, population models, multicenter trials, handling dropouts, survival analysis, robust data analysis, cate